One-third of society is obese, and many are seeking ways to lose weight, according to professor Oktay Banlı, chairperson of ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

The director of the Bariatric and Metabolic Institute at Cleveland Clinic Weston Hospital describes how you can keep up with ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

Researchers are exploring whether microorganisms found in cow’s milk and soil can help prevent weight gain typically caused ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

With obesity amongst young people on the rise, one nutritionist says instilling healthy habits starts at home. Here’s how ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...